Vident Investment Advisory’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,899
| Closed | -$421K | – | 1105 |
|
|
2023
Q2 | $421K | Sell |
2,899
-2,375
| -45% | -$323K | 0.01% | 747 |
|
|
2023
Q1 | $681K | Buy |
5,274
+1,056
| +25% | +$133K | 0.02% | 660 |
|
|
2022
Q4 | $538K | Buy |
4,218
+1,143
| +37% | +$133K | 0.02% | 687 |
|
|
2022
Q3 | $280K | Buy |
3,075
+810
| +36% | +$88.9K | 0.01% | 914 |
|
|
2022
Q2 | $236K | Sell |
2,265
-4,607
| -67% | -$547K | 0.01% | 1081 |
|
|
2022
Q1 | $879K | Buy |
6,872
+3,781
| +122% | +$456K | 0.02% | 741 |
|
|
2021
Q4 | $381K | Sell |
3,091
-2,128
| -41% | -$279K | 0.01% | 998 |
|
|
2021
Q3 | $742K | Buy |
5,219
+2,565
| +97% | +$377K | 0.02% | 766 |
|
|
2021
Q2 | $415K | Sell |
2,654
-5,255
| -66% | -$851K | 0.01% | 882 |
|
|
2021
Q1 | $1.23M | Buy |
7,909
+606
| +8% | +$93.9K | 0.04% | 557 |
|
|
2020
Q4 | $1.09M | Buy |
7,303
+771
| +12% | +$109K | 0.04% | 519 |
|
|
2020
Q3 | $863K | Sell |
6,532
-7,860
| -55% | -$1.03M | 0.04% | 534 |
|
|
2020
Q2 | $1.67M | Buy |
14,392
+5,129
| +55% | +$591K | 0.09% | 260 |
|
|
2020
Q1 | $909K | Sell |
9,263
-11,776
| -56% | -$1.54M | 0.06% | 422 |
|
|
2019
Q4 | $3.06M | Buy |
21,039
+17,187
| +446% | +$2.37M | 0.19% | 103 |
|
|
2019
Q3 | $513K | Buy |
3,852
+40
| +1% | +$5.17K | 0.04% | 333 |
|
|
2019
Q2 | $436K | Sell |
3,812
-23,273
| -86% | -$2.73M | 0.04% | 367 |
|
|
2019
Q1 | $3.36M | Buy |
27,085
+23,121
| +583% | +$2.63M | 0.18% | 106 |
|
|
2018
Q4 | $399K | Sell |
3,964
-34
| -0.9% | -$3.82K | 0.02% | 649 |
|
|
2018
Q3 | $510K | Sell |
3,998
-167
| -4% | -$19.9K | 0.02% | 685 |
|
|
2018
Q2 | $451K | Sell |
4,165
-326
| -7% | -$35.5K | 0.02% | 691 |
|
|
2018
Q1 | $468K | Buy |
4,491
+128
| +3% | +$14.9K | 0.02% | 643 |
|
|
2017
Q4 | $512K | Buy |
4,363
+1,085
| +33% | +$123K | 0.02% | 559 |
|
|
2017
Q3 | $373K | Buy |
+3,278
| New | +$378K | 0.02% | 585 |
|
|
2017
Q1 | – | Sell |
-3,559
| Closed | -$357K | – | 496 |
|
|
2016
Q4 | $357K | Sell |
3,559
-239
| -6% | -$25.6K | 0.04% | 351 |
|
|
2016
Q3 | $479K | Sell |
3,798
-1,634
| -30% | -$202K | 0.06% | 362 |
|
|
2016
Q2 | $635K | Buy |
+5,432
| New | +$615K | 0.09% | 348 |
|
|
2015
Q4 | – | Sell |
-30
| Closed | -$3K | – | 859 |
|
|
2015
Q3 | $3K | Sell |
30
-5,705
| -99% | -$572K | ﹤0.01% | 1001 |
|
|
2015
Q2 | $608K | Buy |
5,735
+541
| +10% | +$59.9K | 0.08% | 373 |
|
|
2015
Q1 | $593K | Sell |
5,194
-83
| -2% | -$9.47K | 0.12% | 294 |
|
|
2014
Q4 | $581K | Buy |
+5,277
| New | +$556K | 0.2% | 182 |
|
Other funds holding ZBH
Vident Investment Advisory's ZBH Position: Q3 2023 in Review
Vident Investment Advisory sold out of Zimmer Biomet (ZBH) in Q3 2023, closing a stake of 2,899 shares — an estimated $421K sold.
Vident Investment Advisory first reported a position in ZBH in Q4 2014 and held it in 31 quarters. The position peaked at $3.36M in Q1 2019. 1,016 funds tracked by Wall St. Rank hold ZBH as of Q3 2023.
- Vident Investment Advisory reported no remaining Zimmer Biomet position as of Q3 2023 after selling out during the quarter.
- Vident Investment Advisory sold 2,899 Zimmer Biomet shares in Q3 2023, an estimated $421K.
- Vident Investment Advisory first reported a position in Zimmer Biomet in Q4 2014 and held it in 31 quarters.
- Vident Investment Advisory's Zimmer Biomet position peaked at $3.36M in Q1 2019.
- 1,016 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2023.
Based on Vident Investment Advisory's 13F filing for Q3 2023.